Reaction
Pharyngeal Erythema reporting signals
As of the last recalculation, Pharyngeal Erythema appears in 2,124 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is FOSAPREPITANT DIMEGLUMINE (PRR 12.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fosaprepitant Dimeglumine | 17 | 12.2 | 12.2 |
| Palivizumab | 18 | 11.6 | 11.6 |
| Mometasone | 21 | 11.3 | 11.3 |
| Indapamide | 20 | 11.0 | 11.0 |
| Ciclesonide | 15 | 10.9 | 10.9 |
| Clarithromycin | 36 | 10.4 | 10.4 |
| Ipratropium Bromide | 36 | 10.0 | 10.1 |
| Aprepitant | 18 | 9.6 | 9.6 |
| Methimazole | 7 | 8.8 | 8.8 |
| Mepolizumab | 40 | 8.0 | 8.0 |
| Salmeterol Xinafoate | 7 | 8.0 | 8.0 |
| Dexamethasone Sodium Phosphate | 8 | 7.7 | 7.7 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 10 | 6.3 | 6.3 |
| Canakinumab | 6 | 5.4 | 5.4 |
| Mirabegron | 20 | 5.1 | 5.1 |
| Fluticasone Propionate And Salmeterol | 21 | 5.0 | 5.0 |
| Oseltamivir | 4 | 4.9 | 4.9 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 5 | 4.7 | 4.7 |
| Brinzolamide | 4 | 4.5 | 4.5 |
| Pegfilgrastim | 20 | 2.0 | 2.0 |
| Nirmatrelvir And Ritonavir | 10 | 1.8 | 1.8 |
| Erenumab-Aooe | 9 | 1.6 | 1.6 |